Hyunju Lee1, Sek Won Kong, Peter J Park. 1. Harvard-Partners Center for Genetics and Genomics, Informatics Program, Children's Hospital, Department of Cardiology, Children's Hospital, Boston, MA, USA.
Abstract
MOTIVATION: DNA copy number aberrations (CNAs) and gene expression (GE) changes provide valuable information for studying chromosomal instability and its consequences in cancer. While it is clear that the structural aberrations and the transcript levels are intertwined, their relationship is more complex and subtle than initially suspected. Most studies so far have focused on how a CNA affects the expression levels of those genes contained within that CNA. RESULTS: To better understand the impact of CNAs on expression, we investigated the correlation of each CNA to all other genes in the genome. The correlations are computed over multiple patients that have both expression and copy number measurements in brain, bladder and breast cancer data sets. We find that a CNA has a direct impact on the gene amplified or deleted, but it also has a broad, indirect impact elsewhere. To identify a set of CNAs that is coordinately associated with the expression changes of a set of genes, we used a biclustering algorithm on the correlation matrix. For each of the three cancer types examined, the aberrations in several loci are associated with cancer-type specific biological pathways that have been described in the literature: CNAs of chromosome (chr) 7p13 were significantly correlated with epidermal growth factor receptor signaling pathway in glioblastoma multiforme, chr 13q with NF-kappaB cascades in bladder cancer, and chr 11p with Reck pathway in breast cancer. In all three data sets, gene sets related to cell cycle/division such as M phase, DNA replication and cell division were also associated with CNAs. Our results suggest that CNAs are both directly and indirectly correlated with changes in expression and that it is beneficial to examine the indirect effects of CNAs. AVAILABILITY: The code is available upon request.
MOTIVATION: DNA copy number aberrations (CNAs) and gene expression (GE) changes provide valuable information for studying chromosomal instability and its consequences in cancer. While it is clear that the structural aberrations and the transcript levels are intertwined, their relationship is more complex and subtle than initially suspected. Most studies so far have focused on how a CNA affects the expression levels of those genes contained within that CNA. RESULTS: To better understand the impact of CNAs on expression, we investigated the correlation of each CNA to all other genes in the genome. The correlations are computed over multiple patients that have both expression and copy number measurements in brain, bladder and breast cancer data sets. We find that a CNA has a direct impact on the gene amplified or deleted, but it also has a broad, indirect impact elsewhere. To identify a set of CNAs that is coordinately associated with the expression changes of a set of genes, we used a biclustering algorithm on the correlation matrix. For each of the three cancer types examined, the aberrations in several loci are associated with cancer-type specific biological pathways that have been described in the literature: CNAs of chromosome (chr) 7p13 were significantly correlated with epidermal growth factor receptor signaling pathway in glioblastoma multiforme, chr 13q with NF-kappaB cascades in bladder cancer, and chr 11p with Reck pathway in breast cancer. In all three data sets, gene sets related to cell cycle/division such as M phase, DNA replication and cell division were also associated with CNAs. Our results suggest that CNAs are both directly and indirectly correlated with changes in expression and that it is beneficial to examine the indirect effects of CNAs. AVAILABILITY: The code is available upon request.
Authors: D G Albertson; B Ylstra; R Segraves; C Collins; S H Dairkee; D Kowbel; W L Kuo; J W Gray; D Pinkel Journal: Nat Genet Date: 2000-06 Impact factor: 38.330
Authors: Jonathan R Pollack; Therese Sørlie; Charles M Perou; Christian A Rees; Stefanie S Jeffrey; Per E Lonning; Robert Tibshirani; David Botstein; Anne-Lise Børresen-Dale; Patrick O Brown Journal: Proc Natl Acad Sci U S A Date: 2002-09-24 Impact factor: 11.205
Authors: Paul N Span; C G J Sweep; Peggy Manders; Louk V A M Beex; David Leppert; Raija L P Lindberg Journal: Cancer Date: 2003-06-01 Impact factor: 6.860
Authors: Ubaradka G Sathyanarayana; Asha Padar; Chun Xian Huang; Makoto Suzuki; Hisayuki Shigematsu; B Nebiyou Bekele; Adi F Gazdar Journal: Clin Cancer Res Date: 2003-12-15 Impact factor: 12.531
Authors: J C M Pole; C Courtay-Cahen; M J Garcia; K A Blood; S L Cooke; A E Alsop; D M L Tse; C Caldas; P A W Edwards Journal: Oncogene Date: 2006-04-24 Impact factor: 9.867
Authors: Anita Sathyanarayanan; Rohit Gupta; Erik W Thompson; Dale R Nyholt; Denis C Bauer; Shivashankar H Nagaraj Journal: Brief Bioinform Date: 2020-12-01 Impact factor: 11.622
Authors: Marina V Protopopova; Vasiliy V Pavlichenko; Ralph Menzel; Anke Putschew; Till Luckenbach; Christian E W Steinberg Journal: Environ Sci Pollut Res Int Date: 2014-07-23 Impact factor: 4.223
Authors: Nimisha Chaturvedi; Jelle J Goeman; Judith M Boer; Wessel N van Wieringen; Renée X de Menezes Journal: BMC Bioinformatics Date: 2014-07-08 Impact factor: 3.169